Animal study backs-up claims for heart laser:
This article was originally published in Clinica
A short-term animal study has backed-up claims that PLC Systems' Heart Laser limits damage after ischaemic events. Researchers at Brigham and Women's Hospital and Harvard Medical School blocked coronary arteries in 18 sheep (Journal of the American College of Cardiology, January). According to Dr Lawrence Cohn, those which also received trans-myocardial revascularisation (TMR) had considerably less heart damage than either those whose arteries remained blocked or were unblocked later. Approximately 200 human patients have undergone TMR in the US.
You may also be interested in...
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.
Belgian developer of cancer diagnostics is building an infectious disease portfolio on the back of its new SARS-CoV-2 test and collaborations with Immunexpress and Endpoint Health.